10x Genomics (TXG) Non-Current Debt (2018 - 2019)
10x Genomics (TXG) posted Non-Current Debt of $19.8 million for Q4 2019, down 11.07% sequentially from $22.3 million in Q3 2019, and down 22.17% YoY from $25.5 million in Q4 2018.
10x Genomics (TXG) Non-Current Debt (2018 - 2019) Analysis & Trends
10x Genomics has reported Non-Current Debt for 2 years, with the latest figure at $19.8 million in Q4 2019.
- Quarterly Non-Current Debt fell 22.17% year-over-year to $19.8 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $19.8 million (down 22.17% YoY) and the FY2019 annual result came in at $19.8 million, down 22.17% from the prior year.
- Non-Current Debt slipped to $19.8 million in Q4 2019 per TXG's latest filing, from $22.3 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $25.5 million in Q4 2018 and troughed at $19.8 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 2.15 Bn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 942.66 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | - |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 1.45 Bn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | - |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Privia Health | 2.78 Bn | 2.42 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 19.84 Mn |
| Sep 30, 2019 | 22.31 Mn |
| Dec 31, 2018 | 25.49 Mn |